Riffa, Kingdom of Bahrain: Within its efforts that are dedicated to providing comprehensive medical care services to patients, Al Salam Specialist Hospital, a leading private hospital in the Kingdom of Bahrain, has recently announced the opening of its Hematology and Oncology Department.

The department provides a wide array of medical oncology services to patients suffering from tumours and blood disorders, as per the latest international and most effective methods.

These services include general oncology diagnosis and treatment services, early diagnosis and treatment of breast cancer for women and prostate cancer for men, in addition to chemotherapy, hormone therapy and preventive therapy, according to the condition of each patient.

Led by renowned oncology consultants, who have long years of experience in the field of cancer diagnosis and treatment, the team of experts at the Hematology and Oncology Department in Al Salam Specialist Hospital consists of experienced assistant doctors, a specialised nursing team and a licensed pharmacist with special training in how to design, give, monitor and change chemotherapy for cancer patients.

The responsibilities of the team are not limited to providing treatment and monitoring cancer patients, but it also include educating them on the benefits and possible side effects of therapy, in addition to precautionary measures and the appropriate approaches to handle the disease.

On the occasion, Al Salam Specialist Hospital CEO Dr. Ramez Elawady, commented: “Opening this key department comes within the pursue of our goal to become the first choice for patients and physicians in the region through the continuous expansion of our services. Cancer has become a common disease in recent years. At Al Salam Specialist Hospital, we are not only focusing on the treatment of cancer patients, but we also work to raise more awareness on the preventive and precautionary measures that could be followed to curb the increasing spread of the disease.”

On his part, Hematology and Oncology Department Head and Senior Oncologist Consultant Dr. Farid Khalifa reiterated that the department is qualified to provide the highest levels of medical care to cancer patients, in addition to the early detection and precautionary measures. Dr. Khalifa confirmed that the department is well equipped to ensure that patients are safely treated and protected from possible side effects of treatment.

“Recent studies and statistics show that the most common cancer cases in recent years are breast, colon, lung, ovarian and endometrial cancer. At the Hematology and Oncology Department, we

follow the different stages of each patient’s case, to ensure they receive the proper diagnosis and treatment, with accordance to their condition,” Dr. Khalifa added.

Al Salam Specialist Hospital offers various services, including inpatient, outpatient, diagnostic, surgical intervention, clinical laboratory, operating theaters, physiotherapy, radiology as well as other medical services.

The hospital comprises of 11 floors, 100 beds, 32 outpatient clinics, 14 royal suites, a 24-hour pharmacy, eight intensive care beds, 10 nursery beds, two neonatal intensive care units, 13 emergency beds, three fully equipped labour rooms, a gastrointestinal endoscopy unit and 260 parking spaces.

For more information or appointments, please call Al Salam Specialist Hospital on 13101010, visit www.alsalam.care, or follow alsalam.care on Instagram, alsalam_care on Twitter or alsalamspecialisthospital on Facebook.

--Ends-

About Al Salam Specialist Hospital
Al Salam Specialist Hospital, located in a strategic location in Riffa by Estiqlal Highway, is designed and equipped to comply with local and international health regulations. It provides a broad range of services such as inpatient, outpatient, diagnostic and interventional services, clinical laboratory, operating rooms, physiotherapy, as well as other medical services.

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.